Ayala Pharmaceuticals Inc (ADXS)

[Simple Steve]

Actually we don't know how many people survived 40 months and how many survived 12 months. Only 8 patients alive (as of Jan 2017) and we know that the range of those survivors was from 12.2 months to 40 months. So there is/was at least one patient who survived 12.2 months and at least one patient who survived at least 40 months. Also we know one patient (the one with complete recovery) survived 18.5 months (as of Jan 2017). But we don't know the survival length of the other 5 patients who still survived. So we can say the survival rate at 40 months is at least 2% since we know 1 patient survived that long. And, with 7 others still alive it's possible a few of them could make it to 40 months too (from when they began treatment). In fact, I would expect the patient with complete recovery would eventually make it to 40 months. So my guess is that 40 month survival rate may be around 5-10%. That sounds like a low chance of survival, but for patients this late stage it might be pretty good. I wonder how that compares to SOC.